Nafazatrom inhibits peroxidation of phosphatidylcholine liposomes, heart homogenate and low density lipoproteins

General Physiology and Biophysics

Volumn 16, Issue 2, 1997, Pages 151-162

  Ondrias K ^a   Stasko A ^b   Gergel, D ^c   Ondriasova E ^d   Hromadova M ^e  

^a INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^b SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^c INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^d Physics and Informatics   (Slovakia)

^e INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

Author keywords

Tocopherol radical; Antioxidant; EPR; Low density lipoproteins; Nafazatrom; Phosphatidylcholine peroxidation

Indexed keywords

2,2' AZOBIS(2 AMIDINOPROPANE); ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIOXIDANT; ASCORBIC ACID; BUTYLCRESOL; LIPOSOME; LOW DENSITY LIPOPROTEIN; NAFAZATROM; PHOSPHATIDYLCHOLINE;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; HEART; LIPID PEROXIDATION; NONHUMAN; RAT; TISSUE HOMOGENATE;

ANIMALS; ANTIOXIDANTS; ELECTRON SPIN RESONANCE SPECTROSCOPY; FIBRINOLYTIC AGENTS; HEART; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; LIPOSOMES; MYOCARDIUM; PHOSPHATIDYLCHOLINES; PYRAZOLES; PYRAZOLONES; RATS; VITAMIN E;

ANIMALIA;

EID: 0030663241     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ardlie N. G., Selley M. L., Simons L. A. (1987): Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis 76, 117-124
2. Bascetta E., Gunstone F. D., Walton J. C. (1983): Electron spin resonance study of the role of vitamin E and vitamin C in the inhibition of fatty acid oxidation in a model membrane. Chem. Phys. Lipids 33, 207-210
3. Björkhem I., Henriksson-Freyschuss A., Breuer O., Diczfalusy U., Berglund L., Henriksson P. (1991): The antioxidant butylated hydroxytoulene protects against atherosclerosis. Arterioscler. Thromb. 11, 15-22
4. Breugnot C., Maziere C., Salmon S., Auclair M., Santus R., Morliere P., Lenaers A., Maziere J. C. (1990): Phenothiazines inhibit copper and endothelial cell-induced peroxidation of low density lipoprotein. Biochem. Pharmacol. 40, 1975-1980
5. Esterbauer H., Jürgens G., Quehenberger O., Koller E. (1987): Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28, 495-509
6. Fiedler V. B. (1984): Reduction of acute myocardial ischemia in rabbit hearts by nafazatrom. J. Cardiovasc. Pharmacol. 7, 18-24
7. Giertlová M., Ondriaš K. (1992): Nifedipine and nimodipine solubility in the presence of diheptanoyl phosphatidylcholine. Pharmazie 47, 861-864
8. Henriksen T., Mahoney E. M., Steinberg D. (1981): Enhanced macrophage degradation of LDL previously incubated with cultured endothelial cells: recognition by receptors for acetylated LDL. Proc. Natl. Acad. Sci. USA 78, 6499-6503
9. Herrmann K. S., Voigt W-H. (1984): Ultrastructural observations of an electron dense amorphous layer on selectively damaged endothelial cells, a possible trigger of thrombogenesis in vivo, and its inhibition by nafazatrom. Thromb. Res. 36, 205-215
10. Hiramatsu M., Velasco R. D., Packer L. (1990): Vitamin E radical reaction with antioxidants in rat liver membranes. Free Radical. Biol. Med. 9, 459-464
11. Huber L. A., Scheffler E., Poll T., Ziegler R., Dresel H. A. (1990): 17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radical. Res. Commun. 8, 167-173
12. Janero D. R., Burghardt B., Lopez R., Cardell M. (1989): Influence of cardioprotective cyclooxygenase and lipoxygenase inhibitors on peroxidative injury to myocardialmembrane phospholipids. Biochem. Pharmacol. 38, 4381-4387
13. Jovanovic S. V., Neta P., Simic M. G. (1985): One-electron redox reactions of pyrazolin5-ones a pulse radiolysis study of antipyrine and analogues. Mol. Pharmacol. 28, 377-380
14. Judd A. M., Login I. S., Ehreth J. T., MacLeod R. M. (1986): Nafazatrom, an arachidonate metabolism inhibitor, decreases prolactin and GH release. Eur. J. Pharmacol. 128, 151-156
15. Marnett L. J., Siedlik P. H., Ochs R. C., Pagels W. R., Das M., Honn K. V., Warnock R. H., Tainer B. E., Eling T. E. (1984): Mechanism of the stimulation of prostaglandin H synthase and prostacyclin synthase by the antithrombotic and antimetastatic agent nafazatrom. Mol. Pharmacol. 26, 328-335
16. McCay P. B. (1985): Vitamin E: interactions with free radicals and ascorbate. Annu. Rev. Nutr. 5, 323-340
17. Motoyama T., Miki M., Mino M., Takahashi M., Niki E. (1989): Synergistic inhibition of oxidation in dispersed phosphatidylcholine liposomes by a combination of vitamin E and cysteine. Arch. Biochem. Biophys. 270, 655-661
18. Niki E. (1987): Interaction of ascorbate and alpha-tocopherol. Ann. N.Y. Acad. Sci. 498, 186-199
19. Niki E., Yamamoto Y., Komuro E., Sato K. (1991): Membrane damage due to lipid oxidation. Amer. J. Clin. Nutr. 53, 201S-205S
20. Ondriaš K., Mišík V., Gergel' D., Staško A. (1989): Lipid peroxidation of phosphatidylcholine liposomes depressed by the calcium channel blockers nifedipine and verapamil and by the antiarrhythmic-antihypoxic drug stobadine. Biochim. Biophys. Acta 1003, 238-245
21. Ondriaš K., Mišík V., Brezová V., Staško A. (1993): Reaction kinetics of alpha-tocopheroxyl radical with biologically and pharmacologically active substances. Free Radical. Res. Commun. 19, 17-28
22. Ondriaš K., Mišík V., Staško A., Gergel' D., Hromadová M. (1994): Comparison of antioxidant properties of nifedipine and illuminated nifedipine with nitroso spin traps in low density lipoproteins and phosphatidylcholine liposomes. Biochim. Biophys. Acta 1211, 114-119
23. Parthasaraty S., Young S. G., Witzum J. L., Pittman R. C., Steinberg D. (1986): Probucol inhibits oxidative modification of low density lipoprotein. Proc. Natl. Acad. Sci. USA 77, 641-644
24. Rousseau-Richard C., Richard C., Martin R. (1988): Kinetics of bimolecular decay of α-tocopheroxyl free radicals studied by ESR. FEBS Lett. 233, 307-310
25. Sato K., Niki E., Shimasaki H. (1990): Free radical-mediated chain oxidation of low density lipoprotein and its synergistic inhibition by vitamin E and vitamin C. Arch. Biochem. Biophys. 279, 402-405
26. Sevilla M. D., Neta P., Marnett L. J. (1983): Reaction of the antithrombotic and antimetastatic agent, nafazatrom. with oxidizing radicals. Biochem. Biophys. Res. Commun. 115, 800-806
27. Seuter F., Bosse W. D., Meng K., Hoffmeister F., Moller E., Horstman H. (1979): The anti-thrombotic activity of Bay g6575. Arzneim. Forsch. 29, 54-59
28. Shea M. J., Murtagh J. J., Jolly S. R., Abrams G. D., Pitt B., Lucchesi B. R. (1984): Beneficial effects of nafazatrom on ischemic reperfused myocardium. Eur. J. Pharmacol. 102, 63-70
29. Steinberg D. (1988): Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis. Atherosclerosis Rev. 18, 1-23
30. Steinbrecher U. P., Parthasaraty S., Leake D. S., Witztum J. L., Steinberg D. (1984): Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 81, 3883-3887
31. Ylä-Herttuala S., Palinski W., Rosenfeld M. E., Parthasaraty S., Carew T., Butler S., Witzum J. L., Steinberg D. (1989): Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84, 1086-1095